2. MAPK/ERK Pathway
  3. p38 MAPK JNK
  4. Hypaphorine

Hypaphorine is an indole found in Caragana korshinskii. Hypaphorine has neurological and glucose-lowering effects. Hypaphorine prevents Lipopolysaccharides (LPS) (HY-D1056)-mediated acute lung injury (ALI) and proinflammatory response via inactivating the p38/JNK signaling pathway by upregulating DUSP1.

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

Hypaphorine

Hypaphorine 構造式

CAS 番号 : 487-58-1

容量 価格（税別） 在庫状況 数量
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in Water
ready for reconstitution
 USD 242 在庫あり
Solution
10 mM * 1 mL in Water USD 242 在庫あり
Solid
1 mg $80 在庫あり
5 mg $220 在庫あり
10 mg $330 在庫あり
25 mg $600 在庫あり
50 mg $900 在庫あり
100 mg $1350 在庫あり
200 mg   お問い合わせ  
500 mg   お問い合わせ  

* アイテムを追加する前、数量をご選択ください

This product is a controlled substance and not for sale in your territory.

カスタマーレビュー

Based on 2 publication(s) in Google Scholar

Other Forms of Hypaphorine:

Hypaphorine 関連抗体

Top Publications Citing Use of Products

p38 MAPK アイソフォーム固有の製品をすべて表示:

すべてのアイソフォームを表示
p38 MAPK Akt1 p38α p38β MAPK13 p38δ p38γ

JNK アイソフォーム固有の製品をすべて表示:

すべてのアイソフォームを表示
JNK1 JNK2 JNK3 JNK

  • 生物活性

  • 純度とドキュメンテーション

  • 参考文献

  • カスタマーレビュー

製品説明

Hypaphorine is an indole found in Caragana korshinskii. Hypaphorine has neurological and glucose-lowering effects. Hypaphorine prevents Lipopolysaccharides (LPS) (HY-D1056)-mediated acute lung injury (ALI) and proinflammatory response via inactivating the p38/JNK signaling pathway by upregulating DUSP1[1][2][3][4].

体外実験

Hypaphorine (6.25-100 μM, 24 h) inhibits the Lipopolysaccharides (LPS) (HY-D1056)-mediated apoptosis of alveolar epithelial cells[2].
Hypaphorine (12.5-50 μM, 48 h) attenuates the expression of inflammatory factors (IL-1β, IL-6, TNF-α, and IL-18) and inactivates the p38/JNK signaling pathway through up-regulating DUSP1 in a dose-dependent manner[2].
Hypaphorine reverses inhibition of E. globulus seedling root growth induced by 3-Indoleacetic acid (Indole-3-acetic acid) (HY-18569)[3].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Hypaphorine 関連抗体

Apoptosis Analysis[2]

Cell Line: BEAS-2B lung epithelial cells
Concentration: 6.25, 12.5, 25, 50, 100 μM
Incubation Time: 24 h
Result: Cell viability was not changed when the dose was less than 50 μM, cell viability decreased significantly at 100 μM.
Cell viability was elevated dose-dependently (12.5, 25, 50 μM) in an ALI model.
The expression of pro-apoptotic proteins Bax and Caspase3 was dampened, while the anti-apoptotic protein Bcl2 was increased significantly in a dose-dependent manner.

RT-PCR[2]

Cell Line: BEAS-2B lung epithelial cells
Concentration: 12.5, 25, 50 μM
Incubation Time: 48 h
Result: Promoted the level of DUSP1 mRNA in dose-dependent manner.
DUSP1 was significantly upregulated after LPS treatment.

Western Blot Analysis[2]

Cell Line: BEAS-2B lung epithelial cells
Concentration: 12.5, 25, 50 μM
Incubation Time: 48 h
Result: Distinctly strengthened the DUSP1 expression and inactivated p38/JNK pathway.
Enhanced DUSP1 protein level and inactivated the p38/JNK signaling pathway after LPS treatment.
体内実験

Hypaphorine (10 mg/kg; i.p.; 2 hours after the LPS injection) relieves LPS induced acute lung injury (ALI) in rats with anti-inflammatory effects[2].
Hypaphorine (50 mg/kg; i.p.; once) has antihyperglycemic activity[4].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Male albino rats of Wistar/Sprague-Dawley strain (8-10 weeks, 160 g) made diabetic by intraperitoneal injection of Streptozotocin (HY-13753)[4]
Dosage: 50 mg/kg
Administration: Intraperitoneal injection (i.p.); once
Result: Showed significant anti-hyperglycemic activity (27.8% at 5 h and 20.4% at 24 h).
Animal Model: Male Sprague-Dawley rats (200-220 g) treated with LPS[2]
Dosage: 10 mg/kg
Administration: Intraperitoneal injection (i.p.); 2 hours after the LPS injection
Result: Alleviated the histological changes in lung tissues induced by LPS, including severe inflammatory cell infiltration, thickened alveolar walls, obvious diffuse edema, narrowed alveolar space, strengthened interstitial congestion, serious pathological damage and higher scores.
Reduced BALF cells and neutrophils increased by LPS.
Attenuated the wet/dry weight ratio, capillary permeability and d myeloperoxidase (MPO) activity facilitated by LPS.
分子量

246.31

分子式

C14H18N2O2
CAS 番号
Appearance

Solid

Color

White to off-white

SMILES

C[N+](C)(C)[C@H](C([O-])=O)CC1=CNC2=CC=CC=C12
Structure Classification
Initial Source
輸送条件

Room temperature in continental US; may vary elsewhere.
保管条件

4°C, sealed storage, away from moisture and light

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
溶剤 & 溶解度
体外: 

H2O : 100 mg/mL (405.99 mM; Need ultrasonic)

DMSO : < 1 mg/mL (insoluble or slightly soluble)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 4.0599 mL 20.2996 mL 40.5992 mL
5 mM 0.8120 mL 4.0599 mL 8.1198 mL
10 mM 0.4060 mL 2.0300 mL 4.0599 mL
View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.

  • Molarity Calculator

  • Dilution Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass
=
Concentration
×
Volume
×
Molecular Weight *

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

一般には略語で表示されます：C1V1 = C2V2

濃度 （開始）

C1

×
体積 （開始）

V1

=
濃度 （終了）

C2

×
体積 （終了）

V2

体内:

For the following dissolution methods, please prepare the working solution directly. It is recommended to prepare fresh solutions and use them promptly within a short period of time.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

  • Protocol 1

    Add each solvent one by one:  PBS

    Solubility: 100 mg/mL (405.99 mM); Clear solution; Need ultrasonic

In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

g

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Calculation results:
Working solution concentration: mg/mL
This product has good water solubility, please refer to the measured solubility data in water/PBS/Saline for details.
The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only.If necessary, please contact MedChemExpress (MCE).
純度とドキュメンテーション

純度: 99.93%

COA (256 KB) RP-HPLC (245 KB) MS (67 KB)

取扱説明書 (2659 KB)
参考文献

Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
H2O 1 mM 4.0599 mL 20.2996 mL 40.5992 mL 101.4981 mL
5 mM 0.8120 mL 4.0599 mL 8.1198 mL 20.2996 mL
10 mM 0.4060 mL 2.0300 mL 4.0599 mL 10.1498 mL
15 mM 0.2707 mL 1.3533 mL 2.7066 mL 6.7665 mL
20 mM 0.2030 mL 1.0150 mL 2.0300 mL 5.0749 mL
25 mM 0.1624 mL 0.8120 mL 1.6240 mL 4.0599 mL
30 mM 0.1353 mL 0.6767 mL 1.3533 mL 3.3833 mL
40 mM 0.1015 mL 0.5075 mL 1.0150 mL 2.5375 mL
50 mM 0.0812 mL 0.4060 mL 0.8120 mL 2.0300 mL
60 mM 0.0677 mL 0.3383 mL 0.6767 mL 1.6916 mL
80 mM 0.0507 mL 0.2537 mL 0.5075 mL 1.2687 mL
100 mM 0.0406 mL 0.2030 mL 0.4060 mL 1.0150 mL

* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.

  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

Hypaphorine Related Classifications

  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

質量   濃度   体積   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

一般には略語で表示されます：C1V1 = C2V2

濃度 （開始） × 体積 （開始） = 濃度 （終了） × 体積 （終了）
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

Hypaphorine487-58-1p38 MAPKJNKc-Jun N-terminal kinasePisolithustinctoriusneurologicalglucosep38/JNKacute lung injuryproinflammatoryInhibitorinhibitorinhibit

最近チェックした製品:

オンラインお問い合わせ

Your information is safe with us. * Required Fields.

製品名

  

カスタマ需要量 *

お名前 *

 

タイトル

メールアドレス *

 

電話番号 *

デパートメント

 

組纖名 *

市区町村

都道府県

国或いは地域 *

      

必ず会社名を記載ください。個人への返信は行いません。

備考

バルクお問い合わせ

Inquiry Information

製品名:
Hypaphorine
製品番号:
HY-N2179
数量:
MCE 日本正規代理店:

カスタマーレビュー

Thank You for Your Feedback!

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

製品名

  

Lot #

お名前 *

 

メールアドレス *

電話番号 *

 

部門 *

組纖名 *

 

国或いは地域 *

備考

Request for HNMR Report

We have received your request and will respond to you as soon as possible.